Funding round
Sail Biomedicines Growth
Reported as "Growth Equity"
Sail Biomedicines, which works in RNA medicine design and engineering in Cambridge, raised $465M in a Growth round announced on 29 Jul 2026. 1 firm took part.
$465M
Amount raised
Not disclosed
Post-money valuation
1
Investors
no lead named
Valuation
What this round says about the price
Sail Biomedicines did not disclose a valuation in this round. It is Sail Biomedicines' first venture round on record, 3 years after it was founded in 2023. No later venture round is on record for Sail Biomedicines.
Sail Biomedicines' funding rounds
This is the only venture round on record for Sail Biomedicines.
- Growth this round 29 Jul 2026 $465M
Investors
Who put money in
1 firm took part; no lead investor was named.
Investors
- Johnson & Johnson new investor
Comparable rounds
How it compares
20 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $69M, and this round was 6.7 times the median. The closest in time, other companies' Growth rounds in Pharmaceutical Products:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Pharmaceutical Products | 16 Jul 2026 | $125M | not disclosed | not named |
| Pharmaceutical Products | 30 Jul 2026 | $31M | not disclosed | Guozhong Capital |
| Pharmaceutical Products | 4 Aug 2026 | $184M | not disclosed | Asymchem Group and Hillhouse |
| Pharmaceutical Products | 24 Jun 2026 | $100M | not disclosed | Decheng Capital |
| Pharmaceutical Products | 7 May 2026 | $250M | not disclosed | Blackstone |
| Pharmaceutical Products | 23 Sep 2026 | $7.6M | not disclosed | not named |
| Pharmaceutical Products | 5 Oct 2026 | $200M | not disclosed | Bain Capital Life Sciences |
| Pharmaceutical Products | 2 Apr 2026 | $123M | not disclosed | Access Biotechnology and Alexandria Venture Investments |
Sources
Where this comes from
Reported by 5 sources.
Questions
Frequently asked
How much did Sail Biomedicines raise in its Growth round?
Sail Biomedicines raised $465M in its Growth round, announced in Jul 2026.
Which investors took part in Sail Biomedicines' Growth round?
Johnson & Johnson.
What was Sail Biomedicines' valuation at the Growth round?
It was not disclosed.
How does it compare with other Growth rounds in Pharmaceutical Products?
20 Growth rounds in Pharmaceutical Products within a year either side disclosed an amount; the median was $69M, and this round was 6.7 times the median.